Back to Directory
ALTx Therapeutics
Founded 2025
Developing small molecule therapies targeting telomere maintenance in cancer
ALTx Therapeutics is a biopharmaceutical company developing small molecule medicines for cancers that depend on alternative lengthening of telomeres. Its programmes target vulnerabilities in the mechanisms these cancer cells use to maintain telomeres and sustain proliferation.
The company builds on research from the Francis Crick Institute, combining target validation and drug discovery with scientific and operational support from Slingshot Therapeutics.